Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400080885Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in cystitis (2 arms), sponsored by Fuyang People's Hospital. Primary endpoints: Incidence of CRBD 0 hours after surgery, Incidence of CRBD 1 hour after surgery and 4 more. Planned start Feb 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400080885.